Opti Capital Management, LP Quant / Systematic

Location: New York, NY

CIK: 0001738654 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value: $585M (0.0% shares, 100.0% debt)

Holdings (31)

— TERADYNE INC 14.0%

Value $81.88M Shares 30,439 Est. Cost $1970.61 Unrealized —

— FIREEYE INC 8.5%

Value $49.99M Shares 52,692 Est. Cost $939.91 Unrealized —

— VERINT SYS INC 8.0%

Value $47.08M Shares 47,193 Est. Cost $1049.69 Unrealized —

— NUTANIX INC 7.3%

Value $42.79M Shares 48,043 Est. Cost $875.04 Unrealized —

— SUPERNUS PHARMACEUTICALS INC 6.4%

Value $37.38M Shares 41,828 Est. Cost $843.38 Unrealized —

— 8X8 INC NEW 5.6%

Value $32.51M Shares 35,950 Est. Cost $887.63 Unrealized —

— CYTOKINETICS INC 5.1%

Value $29.67M Shares 12,500 Est. Cost $1962.56 Unrealized —

— JAZZ INVESTMENTS I LTD 4.9%

Value $28.52M Shares 31,009 Est. Cost $919.60 Unrealized —

— SYNAPTICS INC 4.8%

Value $28.31M Shares 26,500 Est. Cost $1068.34 Unrealized —

— VISHAY INTERTECHNOLOGY INC 4.1%

Value $24M Shares 25,600 Est. Cost $937.70 Unrealized —

— WAYFAIR INC 3.7%

Value $21.75M Shares 12,125 Est. Cost $1793.48 Unrealized —

— NEUROCRINE BIOSCIENCES INC 2.6%

Value $14.99M Shares 9,000 Est. Cost $1665.33 Unrealized —

— NEW RELIC INC 2.2%

Value $12.88M Shares 13,215 Est. Cost $917.76 Unrealized —

— PTC THERAPEUTICS INC 2.0%

Value $11.64M Shares 10,000 Est. Cost $1164.10 Unrealized —

— RAPID7 INC 2.0%

Value $11.47M Shares 8,500 Est. Cost $1249.98 Unrealized —

— OMEROS CORP 1.8%

Value $10.35M Shares 10,000 Est. Cost $915.10 Unrealized —

— PACIRA BIOSCIENCES 1.6%

Value $9.37M Shares 8,545 Est. Cost $969.37 Unrealized —

— INFINERA CORP 1.6%

Value $9.247M Shares 10,500 Est. Cost $866.29 Unrealized —

— TWITTER INC 1.4%

Value $7.945M Shares 8,092 Est. Cost $952.50 Unrealized —

— WIX COM LTD 1.3%

Value $7.83M Shares 4,218 Est. Cost $1856.33 Unrealized —

— LIGAND PHARMACEUTICALS INC 1.3%

Value $7.4M Shares 8,500 Est. Cost $870.59 Unrealized —

— RAMBUS INC DEL 1.2%

Value $7.284M Shares 7,000 Est. Cost $1015.94 Unrealized —

— RETROPHIN INC 1.1%

Value $6.653M Shares 7,973 Est. Cost $834.44 Unrealized —

— PLURALSIGHT INC 1.1%

Value $6.626M Shares 7,500 Est. Cost $883.47 Unrealized —

— OPKO HEALTH INC 1.0%

Value $6.143M Shares 5,908 Est. Cost $978.71 Unrealized —

— REDFIN CORP 1.0%

Value $5.946M Shares 4,000 Est. Cost $1486.50 Unrealized —

— INSMED INC 1.0%

Value $5.861M Shares 6,000 Est. Cost $976.83 Unrealized —

— II-VI INC 1.0%

Value $5.781M Shares 4,843 Est. Cost $1193.68 Unrealized —

— NEOGENOMICS INC 0.9%

Value $5.43M Shares 5,000 Est. Cost $1086.00 Unrealized —

— THERAVANCE INC 0.9%

Value $5.158M Shares 5,200 Est. Cost $932.69 Unrealized —

— INTERCEPT PHARMACEUTICALS IN 0.6%

Value $3.397M Shares 4,500 Est. Cost $829.27 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	TERADYNE INC	30,439	$81.88M	14.0%	$1970.61	—	NOTE 1.250%12/1	880770AG7
—	FIREEYE INC	52,692	$49.99M	8.5%	$939.91	—	NOTE 1.625% 6/0	31816QAD3
—	VERINT SYS INC	47,193	$47.08M	8.0%	$1049.69	—	NOTE 1.500% 6/0	92343XAA8
—	NUTANIX INC	48,043	$42.79M	7.3%	$875.04	—	NOTE 1/1	67059NAB4
—	SUPERNUS PHARMACEUTICALS INC	41,828	$37.38M	6.4%	$843.38	—	NOTE 0.625% 4/0	868459AD0
—	8X8 INC NEW	35,950	$32.51M	5.6%	$887.63	—	NOTE 0.500% 2/0	282914AB6
—	CYTOKINETICS INC	12,500	$29.67M	5.1%	$1962.56	—	NOTE 4.000%11/1	23282WAA8
—	JAZZ INVESTMENTS I LTD	31,009	$28.52M	4.9%	$919.60	—	NOTE 1.500% 8/1	472145AD3
—	SYNAPTICS INC	26,500	$28.31M	4.8%	$1068.34	—	NOTE 0.500% 6/1	87157DAD1
—	VISHAY INTERTECHNOLOGY INC	25,600	$24M	4.1%	$937.70	—	NOTE 2.250% 6/1	928298AP3
—	WAYFAIR INC	12,125	$21.75M	3.7%	$1793.48	—	NOTE 1.125%11/0	94419LAD3
—	NEUROCRINE BIOSCIENCES INC	9,000	$14.99M	2.6%	$1665.33	—	NOTE 2.250% 5/1	64125CAD1
—	NEW RELIC INC	13,215	$12.88M	2.2%	$917.76	—	NOTE 0.500% 5/0	64829BAB6
—	PTC THERAPEUTICS INC	10,000	$11.64M	2.0%	$1164.10	—	NOTE 3.000% 8/1	69366JAB7
—	RAPID7 INC	8,500	$11.47M	2.0%	$1249.98	—	NOTE 1.250% 8/0	753422AB0
—	OMEROS CORP	10,000	$10.35M	1.8%	$915.10	—	NOTE 6.250%11/1	682143AE2
—	PACIRA BIOSCIENCES	8,545	$9.37M	1.6%	$969.37	—	NOTE 2.375% 4/0	695127AD2
—	INFINERA CORP	10,500	$9.247M	1.6%	$866.29	—	NOTE 2.125% 9/0	45667GAC7
—	TWITTER INC	8,092	$7.945M	1.4%	$952.50	—	NOTE 1.000% 9/1	90184LAD4
—	WIX COM LTD	4,218	$7.83M	1.3%	$1856.33	—	NOTE 7/0	92940WAB5
—	LIGAND PHARMACEUTICALS INC	8,500	$7.4M	1.3%	$870.59	—	NOTE 0.750% 5/1	53220KAF5
—	RAMBUS INC DEL	7,000	$7.284M	1.2%	$1015.94	—	NOTE 1.375% 2/0	750917AG1
—	RETROPHIN INC	7,973	$6.653M	1.1%	$834.44	—	NOTE 2.500% 9/1	761299AB2
—	PLURALSIGHT INC	7,500	$6.626M	1.1%	$883.47	—	NOTE 0.375% 3/0	72941BAB2
—	OPKO HEALTH INC	5,908	$6.143M	1.0%	$978.71	—	NOTE 4.500% 2/1	68375NAD5
—	REDFIN CORP	4,000	$5.946M	1.0%	$1486.50	—	NOTE 1.750% 7/1	75737FAA6
—	INSMED INC	6,000	$5.861M	1.0%	$976.83	—	NOTE 1.750% 1/1	457669AA7
—	II-VI INC	4,843	$5.781M	1.0%	$1193.68	—	NOTE 0.250% 9/0	902104AB4
—	NEOGENOMICS INC	5,000	$5.43M	0.9%	$1086.00	—	NOTE 1.250% 5/0	64049MAA8
—	THERAVANCE INC	5,200	$5.158M	0.9%	$932.69	—	NOTE 2.125% 1/1	88338TAB0
—	INTERCEPT PHARMACEUTICALS IN	4,500	$3.397M	0.6%	$829.27	—	NOTE 3.250% 7/0	45845PAA6